肾衰竭成人肾脏替代治疗中的种族与民族差异:基于患者年龄变化的观察性研究
这项回顾性队列研究纳入2011—2018年美国830,402例起始肾衰竭治疗的成人患者,比较不同种族和民族在各年龄段接受移植、腹膜透析、家庭血透与中心血透的差异。结果显示,22~44岁年龄组的绝对差异最明显,调整后非西班牙裔黑人和西班牙裔患者在移植方面的差异最大。
要点
- 总体81%接受中心血透,3.0%接受移植(其中85%为抢先移植,57%为活体供肾),10.5%接受腹膜透析,0.7%接受家庭血透。
- 22~44岁患者中,非西班牙裔白人接受移植、腹膜透析和家庭血透的比例分别为10.9%、19.0%和1.2%,均高于非西班牙裔黑人和西班牙裔患者。
- 调整后22~44岁年龄组移植的相对差异最大,非西班牙裔黑人和西班牙裔患者相对于非西班牙裔白人的调整风险比分别为0.21(95%CI 0.19-0.23)和0.47(95%CI 0.43-0.51)。
核心结论
- 在起始肾衰竭治疗的成人中,移植和家庭透析使用方面的种族与民族差异在 youngest 成人年龄组(22~44岁)最为明显。
研究设计与样本
- 回顾性队列研究,纳入2011—2018年期间起始肾衰竭治疗的830,402例美国成人(年龄>21岁)患者。
- 暴露为患者种族和民族(非西班牙裔黑人、非西班牙裔白人、西班牙裔或其他)及年龄组(22~44、45~64、65~74、75~99岁)。
- 结局为治疗第90天时的治疗方式(移植、腹膜透析、家庭血透或中心血透),采用对数二项回归估计调整风险比。
主要发现
- 81%的患者接受中心血透,3.0%接受移植(85%为抢先移植,57%为活体供肾),10.5%接受腹膜透析,0.7%接受家庭血透。
- 22~44岁患者中,非西班牙裔白人接受移植、腹膜透析和家庭血透的比例分别为10.9%、19.0%和1.2%;非西班牙裔黑人分别为1.8%、13.8%和0.6%,西班牙裔分别为4.4%、16.9%和0.5%(所有差异P<0.001)。
- 调整后22~44岁年龄组移植的相对差异最大,非西班牙裔黑人和西班牙裔患者相对于非西班牙裔白人的调整风险比分别为0.21(95%CI 0.19-0.23)和0.47(95%CI 0.43-0.51)。
局限性
- 种族和民族数据并非自我报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Non-Hispanic Black and Hispanic patients present with kidney failure at younger ages than White patients. Younger patients are also more likely to receive transplants and home dialysis than in-center hemodialysis (ICHD), but it is unknown whether racial and ethnic disparities in treatment differ by age. We compared use of kidney replacement therapies between racial and ethnic groups among patients with incident kidney failure overall and by age. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 830,402 US adult (age >21 years) patients initiating kidney failure treatment during the period of 2011-2018. EXPOSURES: Patient race and ethnicity (non-Hispanic Black, non-Hispanic White, Hispanic, or other) and age group (22-44, 45-64, 65-74, or 75-99 years). OUTCOME: Treatment modality (transplant, peritoneal dialysis [PD], home hemodialysis [HHD], or ICHD) as of day 90 of treatment. ANALYTICAL APPROACH: Differences in treatment modalities were quantified for patient subgroups defined by race and ethnicity and by age. Log-binomial regression models were fit to estimate adjusted risk ratios. RESULTS: 81% of patients were treated with ICHD, 3.0% underwent transplants (85% preemptive, 57% living-donor), 10.5% were treated with PD, and 0.7% were treated with HHD. Absolute disparities in treatment were most pronounced among patients aged 22-44 years. Compared with non-Hispanic White patients, whose percentages of treatment with transplant, PD, and HHD were 10.9%, 19.0%, and 1.2%, respectively, non-Hispanic Black patients were less commonly treated with each modality (unadjusted percentages, 1.8%, 13.8%, and 0.6%, respectively), as were Hispanic patients (4.4%, 16.9%, and 0.5%, respectively; all differences P < 0.001). After adjustment, the largest relative disparities were observed for transplant among the 22-44-year age group; compared with non-Hispanic White patients, the adjusted risk ratios for non-Hispanic Black and Hispanic patients were 0.21 (95% CI, 0.19-0.23) and 0.47 (95% CI, 0.43, 0.51), respectively. LIMITATIONS: Race and ethnicity data not self-reported. CONCLUSIONS: Among adults with incident kidney failure, racial and ethnic disparities in transplant and home dialysis use are most pronounced among the youngest adult patient age group.
引用
- Wilk AS, Cummings JR, Plantinga LC, et al. Racial and Ethnic Disparities in Kidney Replacement Therapies Among Adults With Kidney Failure: An Observational Study of Variation by Patient Age. Am J Kidney Dis. 2022. PMID: 35217093. doi:10.1053/j.ajkd.2021.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。